Delek US (NYSE:DK – Get Free Report) had its target price raised by equities research analysts at UBS Group from $31.00 to $42.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the oil and gas company’s stock. UBS Group’s price objective would indicate a potential upside of 1.28% from the company’s previous close.
A number of other research analysts have also recently commented on the company. Cowen upgraded Delek US from a “sell” rating to a “hold” rating in a research note on Friday, September 19th. Weiss Ratings restated a “sell (d-)” rating on shares of Delek US in a research note on Wednesday, October 8th. Wells Fargo & Company boosted their price objective on shares of Delek US from $43.00 to $53.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Piper Sandler raised their target price on Delek US from $39.00 to $47.00 and gave the company a “neutral” rating in a research note on Friday. Finally, The Goldman Sachs Group increased their price target on Delek US from $28.00 to $39.00 and gave the company a “neutral” rating in a report on Wednesday, October 22nd. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Delek US presently has a consensus rating of “Hold” and a consensus price target of $39.08.
Delek US Trading Up 3.8%
Delek US (NYSE:DK – Get Free Report) last announced its quarterly earnings results on Tuesday, December 6th. The oil and gas company reported $0.05 earnings per share for the quarter. Delek US had a negative net margin of 4.83% and a negative return on equity of 56.40%. The firm had revenue of $2.96 billion for the quarter. On average, sell-side analysts anticipate that Delek US will post -5.5 earnings per share for the current fiscal year.
Insider Activity at Delek US
In related news, EVP Reuven Spiegel sold 27,000 shares of the company’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $41.36, for a total transaction of $1,116,720.00. Following the completion of the transaction, the executive vice president directly owned 23,020 shares in the company, valued at $952,107.20. This represents a 53.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Joseph Israel sold 20,028 shares of the firm’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $41.12, for a total transaction of $823,551.36. Following the transaction, the executive vice president directly owned 62,793 shares in the company, valued at approximately $2,582,048.16. The trade was a 24.18% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 66,489 shares of company stock worth $2,655,285 in the last 90 days. 1.90% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Delek US
A number of large investors have recently made changes to their positions in the business. Arrowstreet Capital Limited Partnership grew its holdings in shares of Delek US by 6,300.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,306,269 shares of the oil and gas company’s stock valued at $42,153,000 after acquiring an additional 1,285,861 shares in the last quarter. T. Rowe Price Investment Management Inc. acquired a new stake in Delek US during the first quarter valued at $13,728,000. Nuveen LLC purchased a new position in Delek US in the first quarter valued at about $13,629,000. Harel Insurance Investments & Financial Services Ltd. grew its stake in Delek US by 113.5% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,601,777 shares of the oil and gas company’s stock valued at $33,926,000 after purchasing an additional 851,458 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Delek US in the 3rd quarter worth about $23,308,000. Institutional investors and hedge funds own 97.01% of the company’s stock.
About Delek US
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Read More
- Five stocks we like better than Delek US
- Transportation Stocks Investing
- Stellantis Makes a High-Stakes Bet on Jeep
- ETF Screener: Uses and Step-by-Step Guide
- Nuclear Energy Earnings: Which Names Won and Lost in Q3
- Why Invest in High-Yield Dividend Stocks?
- Alphabet: Buffett’s Bet on Its Next Phase of Growth
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.
